Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Silva Zupančić-Šalek"'
Autor:
Carmen Escuriola Ettingshausen, Vladimír Vdovin, Nadezhda Zozulya, Pavel Svirin, Tatiana Andreeva, Majda Benedik-Dolničar, Victor Jiménez-Yuste, Lidija Kitanovski, Silva Zupancic-Šalek, Anna Pavlova, Angelika Bátorová, Cesar Montaño Mejía, Gulnara Abdilova, Sigurd Knaub, Martina Jansen, Shannely Lowndes, Larisa Belyanskaya, Olaf Walter, Johannes Oldenburg
Publikováno v:
TH Open, Vol 06, Iss 02, Pp e124-e134 (2022)
Background Immune tolerance induction (ITI) with repeated factor VIII (FVIII) administration is the only strategy proven to eradicate inhibitors. The observational ITI study is evaluating ITI with a range of FVIII products. Methods This subgroup anal
Externí odkaz:
https://doaj.org/article/a52b126df9af4fd18ab2a85705afdb71
Autor:
Hrvoje Holik, Ivan Krečak, Marko Lucijanić, Ivan Samardžić, Danijel Pilipac, Ivana Vučinić Ljubičić, Božena Coha, Alma Kitter Pipić, Blaženka Miškić, Silva Zupančić-Šalek
Publikováno v:
Life, Vol 13, Iss 6, p 1388 (2023)
Background: Osteoarthritis (OA) is a progressive degenerative disease with an inflammatory background. Chronic myeloproliferative neoplasms (MPN) are clonal hematopoietic disorders characterized by chronic inflammation and a tendency for connective t
Externí odkaz:
https://doaj.org/article/be95d397d432430eabfcfc704c41c122
Autor:
Nataša Kalebota, Ruđer Novak, Stela Hrkač, Porin Perić, Grgur Salai, Marko Močibob, Marija Pranjić, Zbyněk Zdráhal, Václav Pustka, Nadica Laktašić Žerjavić, Milan Milošević, Marijo Vodanović, Silva Zupančić Šalek, Lovorka Grgurević
Publikováno v:
Health Science Reports, Vol 7, Iss 9, Pp n/a-n/a (2024)
Abstract Background and Aims The pathophysiology of haemophilic arthropathy (HA) is complex and largely undefined. Proteomic analyses provide insights into the intricate mechanisms of the HA. Our study aimed to identify differentially expressed prote
Externí odkaz:
https://doaj.org/article/2d97c893010041f487157f2a68162960
Autor:
Ana Butkovic, Martina Bago, Irena Preloznik Zupan, Barbara Faganel Kotnik, Ivana Prga, Vesna Bačić Vrca, Silva Zupančić Šalek
Publikováno v:
Studia Psychologica, Vol 64, Iss 1 (2022)
The aim of this study was to examine the association of depressive symptoms, assessed with a longer measure designed and validated for diagnosing or screening for depression, with medication adherence levels in a combined sample from Croatia and Slov
Externí odkaz:
https://doaj.org/article/50cde80ae49f4b7fb1784688a263b104
Autor:
Johnny N. Mahlangu, Jose Luis Lamas, Juan Cristobal Morales, Daniel R. Malan, Silva Zupančić Šalek, Michael Wang, Lisa N. Boggio, Inga Hegemann, Andrzej Mital, Matthew Cardinal, Tong Zhu, Pengling Sun, Steven Arkin
Publikováno v:
British Journal of Haematology. 200:229-239
A phase 1b/2, three-month study of marstacimab, a human monoclonal antibody targeting tissue factor pathway inhibitor (TFPI), was conducted in participants with haemophilia A or B, with or without inhibitors. Participants assigned to four cohorts rec
Autor:
Vesna Bačić Vrca, Martina Bago, Barbara Faganel Kotnik, Ana Butković, Silva Zupančić Šalek, Ivana Prga, Irena Preloznik Zupan
Publikováno v:
Psychiatria Danubina
Volume 33
Issue br 3
Volume 33
Issue br 3
Background: There are only a few studies in patients with haemophilia (PWH) that examined both quality of life and depressive symptoms, with only few studies examining their association. Aim of this study was to examine the association between depres
Autor:
Amy D. Shapiro, Pantep Angchaisuksiri, Jan Astermark, Gary Benson, Giancarlo Castaman, Hermann Eichler, Victor Jiménez-Yuste, Kaan Kavakli, Tadashi Matsushita, Lone Hvitfeldt Poulsen, Allison P. Wheeler, Guy Young, Silva Zupančić-Šalek, Johannes Oldenburg, Pratima Chowdary
Publikováno v:
Shapiro, A D, Angchaisuksiri, P, Astermark, J, Benson, G, Castaman, G, Eichler, H, Jiménez-Yuste, V, Kavakli, K, Matsushita, T, Poulsen, L H, Wheeler, A P, Young, G, Zupančić-Šalek, S, Oldenburg, J & Chowdary, P 2022, ' Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors ', Blood Advances, vol. 6, no. 11, pp. 3422-3432 . https://doi.org/10.1182/bloodadvances.2021006403
Despite current therapies, there remains an unmet need for treatment for patients with hemophilia. The main parts of two phase 2 trials established clinical proof-of-concept for once-daily, subcutaneous concizumab prophylaxis in patients with hemophi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f757ec65c47eeb7f5127acc4d2660912
https://hdl.handle.net/11454/77786
https://hdl.handle.net/11454/77786
Autor:
Víctor Jiménez-Yuste, Gary Benson, Sébastien Lobet, Cedric Hermans, Gerry Dolan, Christoph Königs, Debra Pollard, Declan Noone, Silva Zupančić-Šalek, Hermann Eichler, Maria Elisa Mancuso
Publikováno v:
Blood Reviews, Vol. 52, p. 100890 [1-9] (2022)
The mainstay of hemophilia treatment is to prevent bleeding through regular long-term prophylaxis and to control acute breakthrough bleeds. Various treatment options are currently available for prophylaxis, and treatment decision-making is a challeng
Ruxolitinib as monotherapy in a patient with anaplastic lymphoma kinase positive lung adenocarcinoma
Autor:
Silva Zupančić Šalek, Davorka Mursic, Miroslav Samaržija, Marko Jakopović, Mihovil Roglić, Sonja Badovinac, Marta Koršić
Publikováno v:
Anti-Cancer Drugs. 30:1061-1063
We present unusual treatment outcome in a 59-year- old male diagnosed with metastatic lung adenocarcinoma with a very good response to ruxolitinib as monotherapy. In June 2017, this patient was diagnosed with myeloproliferative neoplasm - Janus-assoc
Autor:
Ranka Serventi Seiwerth, Martina Moric Peric, Alen Ostojić, Vlatka Periša, Pavle Rončević, Ines Bojanić, Nadira Duraković, Igor Aurer, Goran Rinčić, Sandra Bašić-Kinda, Ivana Budisavljević, Marijo Vodanović, Ivo Radman, Silva Zupančić-Šalek, Vedrana Gačić, Dominik Lozić, Dubravka Sertić, Ivan Zekanović
Publikováno v:
Liječnički vjesnik. 140:303-306